Coherus BioSciences Inc (CHRS)
2.035
+0.10
(+5.44%)
USD |
NASDAQ |
Apr 26, 16:00
2.035
0.00 (0.00%)
After-Hours: 18:25
Coherus BioSciences Shareholders Equity (Quarterly): -193.42M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -193.42M |
| September 30, 2023 | -133.60M |
| June 30, 2023 | -174.76M |
| March 31, 2023 | -196.51M |
| December 31, 2022 | -137.42M |
| September 30, 2022 | -97.13M |
| June 30, 2022 | -22.63M |
| March 31, 2022 | 12.56M |
| December 31, 2021 | 97.73M |
| September 30, 2021 | 130.76M |
| June 30, 2021 | 156.22M |
| March 31, 2021 | 127.67M |
| December 31, 2020 | 280.97M |
| September 30, 2020 | 255.73M |
| June 30, 2020 | 213.38M |
| March 31, 2020 | 157.28M |
| December 31, 2019 | 105.21M |
| September 30, 2019 | 56.02M |
| June 30, 2019 | -3.985M |
| March 31, 2019 | -38.52M |
| Date | Value |
|---|---|
| December 31, 2018 | -38.59M |
| September 30, 2018 | 12.39M |
| June 30, 2018 | 63.17M |
| March 31, 2018 | -1.794M |
| December 31, 2017 | 31.82M |
| September 30, 2017 | 56.20M |
| June 30, 2017 | 32.14M |
| March 31, 2017 | 78.18M |
| December 31, 2016 | 20.53M |
| September 30, 2016 | 32.87M |
| June 30, 2016 | -60.89M |
| March 31, 2016 | -66.01M |
| December 31, 2015 | -6.207M |
| September 30, 2015 | 40.57M |
| June 30, 2015 | 96.75M |
| March 31, 2015 | 38.15M |
| December 31, 2014 | 66.80M |
| September 30, 2014 | 9.334M |
| June 30, 2014 | 14.69M |
| December 31, 2013 | -42.38M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-196.51M
Minimum
Mar 2023
280.97M
Maximum
Dec 2020
33.37M
Average
56.02M
Median
Sep 2019
Shareholders Equity (Quarterly) Benchmarks
| AbbVie Inc | 10.36B |
| Inovio Pharmaceuticals Inc | 117.35M |
| Nektar Therapeutics | 130.99M |
| Avid Bioservices Inc | 180.17M |
| Stereotaxis Inc | 21.92M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 629.60M |
| Total Liabilities (Quarterly) | 823.03M |
| Debt to Equity Ratio | -2.447 |
| Current Ratio | 1.434 |
| Net Debt Paydown Yield | -0.15% |